PA
VIR icon

Parallel Advisors’s Vir Biotechnology VIR Stock Holding History

Parallel Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$723 Hold
71
– – ﹤0.01% 3740
2026
Q1 		$636 Buy
+71
New +$566 ﹤0.01% 3629
2025
Q4 		– Sell
-468
Closed -$2.67K – 3757
2025
Q3 		$2.67K Hold
468
– – ﹤0.01% 2978
2025
Q2 		$2.36K Sell
468
-44
-9% -$236 ﹤0.01% 3000
2025
Q1 		$3.32K Hold
512
– – ﹤0.01% 2820
2024
Q4 		$3.76K Hold
512
– – ﹤0.01% 2744
2024
Q3 		$3.83K Sell
512
-265
-34% -$2.3K ﹤0.01% 2709
2024
Q2 		$6.92K Sell
777
-74
-9% -$710 ﹤0.01% 2440
2024
Q1 		$8.62K Hold
851
– – ﹤0.01% 2368
2023
Q4 		$8.56K Buy
851
+352
+71% +$3.22K ﹤0.01% 2347
2023
Q3 		$4.68K Sell
499
-5
-1% -$71 ﹤0.01% 2520
2023
Q2 		$12.4K Sell
504
-73
-13% -$1.83K ﹤0.01% 2084
2023
Q1 		$13.4K Buy
577
+567
+5,670% +$14.5K ﹤0.01% 2015
2022
Q4 		$253 Sell
10
-7
-41% -$172 ﹤0.01% 3155
2022
Q3 		$0 Sell
17
-6
-26% -$153 ﹤0.01% 3514
2022
Q2 		$1K Buy
23
+13
+130% +$304 ﹤0.01% 2877
2022
Q1 		$0 Sell
10
-44
-81% -$1.3K ﹤0.01% 3289
2021
Q4 		$2K Sell
54
-20,725
-100% -$812K ﹤0.01% 2770
2021
Q3 		$904K Sell
20,779
-10,383
-33% -$450K 0.04% 272
2021
Q2 		$1.47M Buy
31,162
+22,364
+254% +$1.02M 0.06% 198
2021
Q1 		$451K Sell
8,798
-4,787
-35% -$258K 0.02% 371
2020
Q4 		$364K Hold
13,585
– – 0.02% 398
2020
Q3 		$466K Buy
13,585
+12,528
+1,185% +$539K 0.03% 322
2020
Q2 		$43K Buy
+1,057
New +$35.5K ﹤0.01% 1110

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parallel Advisors's VIR Position: Q2 2026 in Review

Parallel Advisors held its Vir Biotechnology (VIR) position steady in Q2 2026 at 71 shares worth $723. The position accounts for ﹤0.01% of the portfolio, ranked #3740.

Parallel Advisors first reported a position in VIR in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.47M in Q2 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Parallel Advisors held 71 shares of Vir Biotechnology worth $723 as of Q2 2026.
  • Parallel Advisors left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3740 holding.
  • Parallel Advisors first reported a position in Vir Biotechnology in Q2 2020 and has held it in 24 quarters since.
  • Parallel Advisors's Vir Biotechnology position peaked at $1.47M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.